BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7749858)

  • 1. A common variant in the gene for lipoprotein lipase (Asp9-->Asn). Functional implications and prevalence in normal and hyperlipidemic subjects.
    Mailly F; Tugrul Y; Reymer PW; Bruin T; Seed M; Groenemeyer BF; Asplund-Carlson A; Vallance D; Winder AF; Miller GJ
    Arterioscler Thromb Vasc Biol; 1995 Apr; 15(4):468-78. PubMed ID: 7749858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The LPL gene in individuals with familial combined hyperlipidemia and decreased LPL activity.
    Nevin DN; Brunzell JD; Deeb SS
    Arterioscler Thromb; 1994 Jun; 14(6):869-73. PubMed ID: 8199176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic variant showing a positive interaction with beta-blocking agents with a beneficial influence on lipoprotein lipase activity, HDL cholesterol, and triglyceride levels in coronary artery disease patients. The Ser447-stop substitution in the lipoprotein lipase gene. REGRESS Study Group.
    Groenemeijer BE; Hallman MD; Reymer PW; Gagné E; Kuivenhoven JA; Bruin T; Jansen H; Lie KI; Bruschke AV; Boerwinkle E; Hayden MR; Kastelein JJ
    Circulation; 1997 Jun; 95(12):2628-35. PubMed ID: 9193431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of association of the apolipoprotein A-I-C-III-A-IV gene XmnI and SstI polymorphisms and of the lipoprotein lipase gene mutations in familial combined hyperlipoproteinemia in French Canadian subjects.
    Marcil M; Boucher B; Gagné E; Davignon J; Hayden M; Genest J
    J Lipid Res; 1996 Feb; 37(2):309-19. PubMed ID: 9026529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of DNA changes in the LPL gene in patients with familial combined hyperlipidemia.
    Gagné E; Genest J; Zhang H; Clarke LA; Hayden MR
    Arterioscler Thromb; 1994 Aug; 14(8):1250-7. PubMed ID: 8049185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoprotein lipase gene mutations D9N and N291S in four pedigrees with familial combined hyperlipidaemia.
    de Bruin TW; Mailly F; van Barlingen HH; Fisher R; Castro Cabezas M; Talmud P; Dallinga-Thie GM; Humphries SE
    Eur J Clin Invest; 1996 Aug; 26(8):631-9. PubMed ID: 8872057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of the lipoprotein lipase asparagine 291-->serine mutation with body mass index determines elevated plasma triacylglycerol concentrations: a study in hyperlipidemic subjects, myocardial infarction survivors, and healthy adults.
    Fisher RM; Mailly F; Peacock RE; Hamsten A; Seed M; Yudkin JS; Beisiegel U; Feussner G; Miller G; Humphries SE
    J Lipid Res; 1995 Oct; 36(10):2104-12. PubMed ID: 8576637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The lipoprotein lipase (Asn291-->Ser) mutation is associated with elevated lipid levels in families with familial combined hyperlipidaemia.
    Hoffer MJ; Bredie SJ; Boomsma DI; Reymer PW; Kastelein JJ; de Knijff P; Demacker PN; Stalenhoef AF; Havekes LM; Frants RR
    Atherosclerosis; 1996 Jan; 119(2):159-67. PubMed ID: 8808493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A mutation in the promoter of the lipoprotein lipase (LPL) gene in a patient with familial combined hyperlipidemia and low LPL activity.
    Yang WS; Nevin DN; Peng R; Brunzell JD; Deeb SS
    Proc Natl Acad Sci U S A; 1995 May; 92(10):4462-6. PubMed ID: 7753827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Asn9 variant of lipoprotein lipase is associated with the -93G promoter mutation and an increased risk of coronary artery disease. The Regress Study Group.
    Kastelein JJ; Groenemeyer BE; Hallman DM; Henderson H; Reymer PW; Gagné SE; Jansen H; Seidell JC; Kromhout D; Jukema JW; Bruschke AV; Boerwinkle E; Hayden MR
    Clin Genet; 1998 Jan; 53(1):27-33. PubMed ID: 9550358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two novel apolipoprotein A-IV variants in individuals with familial combined hyperlipidemia and diminished levels of lipoprotein lipase activity.
    Deeb SS; Nevin DN; Iwasaki L; Brunzell JD
    Hum Mutat; 1996; 8(4):319-25. PubMed ID: 8956036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patients with apoE3 deficiency (E2/2, E3/2, and E4/2) who manifest with hyperlipidemia have increased frequency of an Asn 291-->Ser mutation in the human LPL gene.
    Zhang H; Reymer PW; Liu MS; Forsythe IJ; Groenemeyer BE; Frohlich J; Brunzell JD; Kastelein JJ; Hayden MR; Ma Y
    Arterioscler Thromb Vasc Biol; 1995 Oct; 15(10):1695-703. PubMed ID: 7583546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Point mutations in lipoprotein lipase (LPL) gene: prevalence in normal and combined hyperlipidemic subjects.
    Gehrisch S; Steinke M; Kostka H; Hoche I; Julius U; Jaross W
    Z Gastroenterol; 1996 Jun; 34 Suppl 3():64-5. PubMed ID: 8767466
    [No Abstract]   [Full Text] [Related]  

  • 14. A missense (Asp250----Asn) mutation in the lipoprotein lipase gene in two unrelated families with familial lipoprotein lipase deficiency.
    Ishimura-Oka K; Semenkovich CF; Faustinella F; Goldberg IJ; Shachter N; Smith LC; Coleman T; Hide WA; Brown WV; Oka K
    J Lipid Res; 1992 May; 33(5):745-54. PubMed ID: 1619366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of mutations in low density lipoprotein receptor (LDLR) and lipoprotein lipase (LPL) genes to familial combined hyperlipidemia (FCHL): a reappraisal by using a resequencing approach.
    Minicocci I; Prisco C; Montali A; Di Costanzo A; Ceci F; Pigna G; Arca M
    Atherosclerosis; 2015 Oct; 242(2):618-24. PubMed ID: 26342331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homozygosity for two point mutations in the lipoprotein lipase (LPL) gene in a patient with familial LPL deficiency: LPL(Asp9-->Asn, Tyr262-->His).
    Rouis M; Lohse P; Dugi KA; Lohse P; Beg OU; Ronan R; Talley GD; Brunzell JD; Santamarina-Fojo S
    J Lipid Res; 1996 Mar; 37(3):651-61. PubMed ID: 8728326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular screening of the lipoprotein lipase gene in hypertriglyceridemic members of familial noninsulin-dependent diabetes mellitus families.
    Elbein SC; Yeager C; Kwong LK; Lingam A; Inoue I; Lalouel JM; Wilson DE
    J Clin Endocrinol Metab; 1994 Nov; 79(5):1450-6. PubMed ID: 7962342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A newly identified heterozygous lipoprotein lipase gene mutation (Cys239-->stop/TGC972-->TGA; LPLobama) in a patient with primary type IV hyperlipoproteinemia.
    Takagi A; Ikeda Y; Mori A; Tsutsumi Z; Oida K; Nakai T; Yamamoto A
    J Lipid Res; 1994 Nov; 35(11):2008-18. PubMed ID: 7868979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel frameshift mutation in exon 6 (the site of Asn 291) of the lipoprotein lipase gene in type I hyperlipidemia.
    Kobayashi J; Nagashima I; Taira K; Hikita M; Tamura K; Bujo H; Morisaki N; Saito Y
    Clin Chim Acta; 1999 Jul; 285(1-2):173-82. PubMed ID: 10481934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial lipoprotein lipase (LPL) deficiency: a catalogue of LPL gene mutations identified in 20 patients from the UK, Sweden, and Italy.
    Mailly F; Palmen J; Muller DP; Gibbs T; Lloyd J; Brunzell J; Durrington P; Mitropoulos K; Betteridge J; Watts G; Lithell H; Angelico F; Humphries SE; Talmud PJ
    Hum Mutat; 1997; 10(6):465-73. PubMed ID: 9401010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.